Development of Effective Tumor Vaccine Strategies Based on Immune Response Cascade Reactions

To solve the problems of high toxicity and poor efficacy of existing tumor treatment methods, researchers have developed a variety of tumor immunotherapies. Among them, tumor vaccines activate antigen‐presenting cells and T lymphocytes upstream of the cancer‐immunity cycle are considered the most promising therapy to activate the immune system. Nanocarriers are considered the most promising tumor vaccine delivery vehicles, including polymer...